Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 61 AL 75

Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint

Kushwah S, Maurya NS, Kushwaha S, Scotti L, Chawade A, Mani A.

Curr Neuropharmacol. 2023;21(4):764-776. doi: 10.2174/1570159X21666230216094353.

Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects

Qian H, Yu C, Zhu H, Ding Q, Cai Y, Jing J, Xu X, Guo R, Zhang H, Liu H, Chen X, Liu Y.

Clin Transl Sci. 2023 May;16(5):810-822. doi: 10.1111/cts.13490. Epub 2023 Feb 26.

Research progress of natural products and their derivatives against Alzheimer's disease

Liu JY, Guo HY, Quan ZS, Shen QK, Cui H, Li X.

J Enzyme Inhib Med Chem. 2023 Dec;38(1):2171026. doi: 10.1080/14756366.2023.2171026.

Lessons from antiamyloid-β immunotherapies in Alzheimer's disease

Plascencia-Villa G, Perry G.

Handb Clin Neurol. 2023;193:267-292. doi: 10.1016/B978-0-323-85555-6.00019-9.

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Gueorguieva I, Willis BA, Chua L, Chow K, Ernest CS, Shcherbinin S, Ardayfio P, Mullins GR, Sims JR.

Clin Pharmacol Ther. 2023 Jun;113(6):1258-1267. doi: 10.1002/cpt.2875. Epub 2023 Mar 9.

Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β

Vogt AS, Jennings GT, Mohsen MO, Vogel M, Bachmann MF.

Int J Mol Sci. 2023 Feb 15;24(4):3895. doi: 10.3390/ijms24043895.

Gut Microbiota and Alzheimer's Disease: How to Study and Apply Their Relationship

Nguyen NM, Cho J, Lee C.

Int J Mol Sci. 2023 Feb 17;24(4):4047. doi: 10.3390/ijms24044047.

Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects

Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE.

Inflammopharmacology. 2023 Jun;31(3):1107-1115. doi: 10.1007/s10787-023-01163-7. Epub 2023 Feb 28.

Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Dubois B, López-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators.

Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x.

Lecanemab: First Approval

Hoy SM.

Drugs. 2023 Mar;83(4):359-365. doi: 10.1007/s40265-023-01851-2.

Insights on benzodiazepines' potential in Alzheimer's disease

Al-Kuraishy HM, Al-Gareeb AI, Alsayegh AA, Abusudah WF, Almohmadi NH, Eldahshan OA, Ahmed EA, Batiha GE.

Life Sci. 2023 May 1;320:121532. doi: 10.1016/j.lfs.2023.121532. Epub 2023 Feb 28.

The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double-blind, controlled trial

Tamtaji OR, Heidari-Soureshjani R, Asemi Z, Kouchaki E.

Phytother Res. 2023 Jul;37(7):2957-2964. doi: 10.1002/ptr.7791. Epub 2023 Mar 2.

Neuroinflammation in Alzheimer's disease: potential beneficial effects of vitamin D

Kouba BR, Camargo A, Rodrigues ALS.

Metab Brain Dis. 2023 Mar;38(3):819-829. doi: 10.1007/s11011-023-01188-5. Epub 2023 Mar 2.

Traditional Chinese Patent Medicine in the Treatment of Alzheimer's Disease: A Systematic Review and Network Meta-Analysis

Liu C, Zhang L, Li Y, Li M, Han H, Wang K.

Am J Chin Med. 2023;51(3):517-546. doi: 10.1142/S0192415X2350026X. Epub 2023 Feb 28.

The past and present of therapeutic strategy for Alzheimer's diseases: potential for stem cell therapy

Murayama MA.

Exp Anim. 2023 Aug 7;72(3):285-293. doi: 10.1538/expanim.22-0164. Epub 2023 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias